Tobacco smoking among people living with a psychotic illness: The second Australian survey of psychosis

Cooper, Jae; Mancuso, Serafino G.; Borland, Ron; Slade, Tim; Galletly, Cherrie; Castle, David

doi:10.1177/0004867412449876

Cited by 153 publications

(168 citation statements)

References 55 publications

Supporting

Mentioning

152

Contrasting

Unclassified

Order By: Relevance

“…However, the prevalence is higher as compared to that reported in studies carried out among the students of Aksum University (Gebreslassie et al, 2013), Hawassa University in Ethiopia (Kassa and Deyno, 2014) and in school adolescents in Nigeria (Raji et al, 2013) which revealed 9.3, 7.5 and 8.3% prevalence respectively. These findings were significantly lower than a similar study done in Australia, Timor and Mekelle, in which the current prevalence were 66.6, 40.3 and 29.5% respectively (Cooper et al, 2012;Siziya et al, 2008;Eticha and Kidane, 2014). Our findings were also lower than a similar study done in Spain, Tanzania and Yemen where the prevalence rate of cigarette smoking was 54.54, 38.6 and 24.3% respectively (Bobes et al, 2010;Hauli et al, 2011;Abbas et al, 2014).…”

Section: Discussioncontrasting

confidence: 78%

“…A research done in Australia discovered that the prevalence of current cigarette smoking was 66.6% (72% of males and 59% of females). In that study, the current frequency of cigarette smoking in schizophrenia, bipolar disorder and depressive disorders were 70, 61 and 58% respectively (Cooper et al, 2012). The smoking rate among people with bipolar disorder has been reported as 61% reported in the US (Lasser et al, 2000).…”

Section: Introductionmentioning

confidence: 77%

See 1 more Smart Citation

Cigarette smoking among Jimma University Teaching and referral hospital outpatients attending services at psychiatry clinic Southwest, Ethiopia

Zenebe¹,

Feyissa²,

Krahl³

2016

J. Neurosci. Behav. Health

View full text Add to dashboard Cite

Smoking is currently considered one of the greatest problems in public health worldwide, and it is one of the most avoidable causes of death. Cigarette consumption killed more than 6 million people, nearly 80% in low and middle income countries in 2011. The objective of the current study was to assess the prevalence of cigarette smoking and its determinant factors among psychiatric outpatients in Jimma University Specialized Hospital (JUSH). A facility based cross-sectional study was carried out in persons with mental disorders from 1st to 15th of August 2013 in Jimma zone, south-west Ethiopia. The data were collected by interviewing all persons with mental disorders coming for treatment at JUSH by using an interviewer administered questionnaire. The overall current prevalence of cigarette smoking was 20.5%. The prevalence of cigarette smoking in persons with schizophrenia, bipolar I disorders and major depressive disorders were 28.2, 17.8 and 16.3%, respectively. Cigarette smoking was strongly associated with male gender, khat use and alcohol use disorders. The current prevalence of cigarette smoking was high amongst persons with mental disorders. Attention should be given routine screening for cigarette smoking in psychiatric patients and consequent management of smoking along with psychiatric management.

show abstract

Section: Discussioncontrasting

confidence: 78%

Section: Introductionmentioning

confidence: 77%

Cigarette smoking among Jimma University Teaching and referral hospital outpatients attending services at psychiatry clinic Southwest, Ethiopia

Zenebe¹,

Feyissa²,

Krahl³

2016

J. Neurosci. Behav. Health

View full text Add to dashboard Cite

show abstract

“…disorder have greater difficulty in quitting than the general population (Cooper et al, 2012), and as such it is not surprising that few participants successfully abstained from smoking without further cessation aids post discharge. These findings are consistent with previous research conducted in general medical settings indicating that a postdischarge effect on smoking rates is most likely to occur when cessation support is provided to patients post discharge, in addition to that provided during the inpatient stay (Rigotti et al, 2012).…”

Section: Australian and New Zealand Journal Of Psychiatry 48(7)mentioning

confidence: 99%

The impact of a smoke-free psychiatric hospitalization on patient smoking outcomes: a systematic review

Stockings

Bowman

Prochaska

et al. 2014

Aust N Z J Psychiatry

View full text Add to dashboard Cite

Objective: Smoke-free policies have been introduced in inpatient psychiatric facilities in most developed nations. Such a period of supported abstinence during hospitalization may impact smoking behaviours post discharge, yet little quantitative evidence exists. The aim of this review was to provide the first synthesis of the research evidence examining the impact of a smoke-free psychiatric hospitalization on patients' smoking-related behaviours, motivation, and beliefs. Methods:We conducted a systematic review of electronic databases PubMed, MEDLINE, PsycINFO, and EMBASE from inception to June 2013. Studies were included if they were conducted in an inpatient psychiatric facility with a smokefree policy and if they examined any change in patients' smoking-related behaviours, motivation, or beliefs either during admission, post discharge, or both. Risk of bias was assessed using the Cochrane Collaboration Risk of Bias Tool.Results: Fourteen studies were included in the review. Of the four studies that assessed change in smoking from admission to post discharge, two indicated a significant decline in cigarette consumption up to 3 months post discharge. Positive changes in motivation to quit and beliefs about quitting ability were identified in two studies. One study reported an increase in the rate of quit attempts and one reported a decline in nicotine dependence levels. Conclusions:A smoke-free psychiatric hospitalization may have a positive impact on patients' smoking-related behaviours, motivation, and beliefs, both during admission and up to 3 months post discharge. Further controlled studies with more rigorous designs are required to confirm this potential.

show abstract

“…About 60%-70% of people with schizophrenia smoke (compared with about 25% of the general population) and this has obvious health implications. 10 In addition, obesity, metabolic syndrome, and diabetes are more common in people with schizophrenia. The recent Australian national survey found that 41% of 1,825 adults with psychotic disorders had attended an emergency department in the previous 12 months, with 21% attending for physical health problems and 26% for acute psychiatric problems.…”

Section: Costs Of Schizophreniamentioning

confidence: 99%

Role of cognitive enhancement in schizophrenia

Galletly¹

2014

NAN

Self Cite

View full text Add to dashboard Cite

Schizophrenia is a severe and usually chronic psychiatric disorder characterized by dysfunction in many domains. Hallucinations, delusions, and behavioral disturbances are prominent symptoms of the illness, and are appropriately a focus for treatment, but less attention is given to the cognitive deficits that are also typically found in schizophrenia. Whilst impairments in learning, memory, and executive function have been recognized for many decades, deficits in more subtle aspects of cognition have been recognized more recently. These include biases in the evaluation of information and difficulties with emotional and social cognition. Cognitive deficits make a substantial contribution to real-world function, and improving cognition has the potential to improve social and vocational outcomes. This review provides an overview of potential treatments for cognitive deficits in schizophrenia, including medications, psychological therapies, and neurostimulation. Despite optimal medication and case management, many people with schizophrenia do not achieve full remission. There is sufficient evidence to encourage widespread adoption of at least some of the current cognitive enhancement strategies. However, individual patients differ in terms of their symptoms, patterns of cognitive dysfunction, medication response, and social and occupational situations. Considerable work is therefore needed to personalize cognitive remediation to maximize the benefits. However, at present, these methods are underutilized, even when applied in a universal manner where all subjects receive the same treatment. The barriers to wider availability of these treatments are discussed.

show abstract

Tobacco smoking among people living with a psychotic illness: The second Australian survey of psychosis

Abstract: The prevalence of tobacco smoking is high amongst people with a psychotic disorder, and is associated with adverse mental health symptoms as well as high rates of other substance use, poorer subjective physical health, and a higher risk of the many known health consequences of smoking.

Cited by 153 publications

References 55 publications

Cigarette smoking among Jimma University Teaching and referral hospital outpatients attending services at psychiatry clinic Southwest, Ethiopia

Cigarette smoking among Jimma University Teaching and referral hospital outpatients attending services at psychiatry clinic Southwest, Ethiopia

The impact of a smoke-free psychiatric hospitalization on patient smoking outcomes: a systematic review

Role of cognitive enhancement in schizophrenia

Contact Info

Product

Resources

About